Several major pharmaceutical companies have reported their quarterly earnings, with mixed results. CME Group reported earnings per share (EPS) of $2.5 against forecasts of $2.45 and revenue of $1.5 billion, surpassing the expected $1.48 billion, with a market cap of $78.05 billion. AstraZeneca's EPS was $1.03, beating estimates of $0.9644, with revenue reaching $12.68 billion against forecasts of $11.79 billion and a market cap of $231.67 billion. Sanofi, however, missed its revenue forecast with $10.46 billion compared to the expected $11.47 billion, though its EPS of $1.78 exceeded the forecast of $0.93, with a market cap of $122.12 billion. Merck reported a strong quarter with an EPS of $2.07, outperforming the forecast of $1.93, and revenue of $15.8 billion against a forecast of $15.22 billion, with a market cap of $321.69 billion. Bristol-Myers Squibb reported an adjusted EPS loss of $4.40, slightly better than the expected loss of $4.44, and revenue of $11.9 billion, above the forecast of $11.46 billion, with a market cap of $99.03 billion. The company also announced plans for $1.5 billion in cost cuts, including laying off about 2,200 employees, which is approximately 6% of its workforce.